Structure–activity relationship studies of Imidazo[1′,2′:1,6]pyrido[2,3-d]pyrimidine derivatives to develop selective FGFR inhibitors as anticancer agents for FGF19-overexpressed hepatocellular carcinoma

Update your browser to view ScienceDirect.

Request details:

Request ID: 8e5f8412be727aec-LAX
IP: 116.62.10.13
UTC time: 2024-11-21T09:05:04+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4